Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-ranging study of KHK4563 in uncontrolled suspected eosinophilic asthma
jRCT2080221534Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of benralizumab in asthma (4 arms), sponsored by Kyowa Kirin.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080221534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221534.